top of page

DRAIGON Consortium website launch

The DRAIGON Consortium launched its website!


The project's objective is to create a cutting-edge in vitro diagnostic device (IVD) that combines artificial intelligence (AI) with whole-genome sequencing (WGS) for the rapid and accurate diagnosis of patients infected multi-drug resistance (MDR) microorganisms and to reduce the prevalence of antimicrobial resistance (AMR).

DRAIGON Consortium is a collaborative initiative supported by key partners including the European Vaccine Initiative (EVI), UMCG research, CAMTECH, Orthopädisches Spital Speising, Health-Ecore, Isala (ziekenhuis), The Johns Hopkins University, Sandoz, and Spitali Universitar Shefqet Ndroqi. This website's launch is part of Draigon's larger effort to foster better communication and cooperation by creating and providing access to cutting-edge research and technology.




 

Read more about the project at DRAIGON Consortium’s website https://www.draigon.eu/ 



PROJECT COORDINATOR

European Vaccine Initiative (EVI)                   


CONTACT

Adriana Vives

European Vaccine Initiative (EVI) - Project Manager

PROJECT COORDINATOR

 

留言


Stay informed about our progress, latest research findings, and upcoming events by subscribing to our newsletter via the European Vaccine Initiative  (DRAIGON's project coordinator) .

Thanks for subscribing!

Sign up to newsletter
Original logo.png

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101137383.

Social media accounts

X-icon-round-corners.png
EN_FundedbytheEU_RGB_PORTFOLIO.png

©2025 by DRAIGON Consortium

bottom of page